Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis

OBJECTIVE: Little information is available about the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) for patients with secondary myelofibrosis from essential thrombocythemia (ET) and polycythemia vera (PV). A nationwide retrospective study of the outcome of HSCT for post-ET and...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Makoto, Suzuki, Ritsuro, Nishida, Tetsuya, Shirane, Shuichi, Shimazu, Yutaka, Minami, Yosuke, Mori, Takehiko, Doki, Noriko, Kanda, Yoshinobu, Uchida, Naoyuki, Tanaka, Masatsugu, Ishikawa, Jun, Togitani, Kazuto, Fukuda, Takahiro, Ichinohe, Tatsuo, Atsuta, Yoshiko, Nagamura-Inoue, Tokiko, Kiyoi, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492130/
https://www.ncbi.nlm.nih.gov/pubmed/32801269
http://dx.doi.org/10.2169/internalmedicine.4375-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492130/
https://www.ncbi.nlm.nih.gov/pubmed/32801269
http://dx.doi.org/10.2169/internalmedicine.4375-19

Ejemplares similares